Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rubius Therapeutics, Inc. | 25,000 | reported | 12 May 2022 | tx 3+100,000 |
| Kaleido Biosciences, Inc. | 15,000 | reported | 30 Jun 2021 | tx 3+60,000 |
| Galecto, Inc. | 720 | reported | 18 Jun 2025 | tx 7+96,720 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Jun 2025 | GRANT_AWARD | Galecto, Inc. | 720 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 12 May 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 30 Jun 2021 | GRANT_AWARD | Kaleido Biosciences, Inc. | 15,000 | 0.00 USD | deriv |
| 26 May 2021 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 12 May 2021 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 08 Jan 2021 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 08 Jan 2021 | GRANT_AWARD | Galecto, Inc. | 6,000 | 0.00 USD | deriv |
| 30 Jun 2020 | GRANT_AWARD | Kaleido Biosciences, Inc. | 15,000 | 0.00 USD | deriv |
| 01 Apr 2020 | GRANT_AWARD | Kaleido Biosciences, Inc. | 30,000 | 0.00 USD | deriv |
| 31 Dec 2019 | GRANT_AWARD | Rubius Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |